Results of the newborn screening program for congenital adrenal hyperplasia in Berlin (1992-1999);Ergebnisse des neugeborenen-screenings zur fruherkennung des adrenogenitalen syndroms in Berlin (1992-1999)

Monatsschrift fur Kinderheilkunde

Volumn 148, Issue 11, 2000, Pages 1006-1011

  Schnabel, D ^a   L'Allemand, D ^a   Krude, H ^a   Keller, E ^b   Gruters A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

CAH; Neonatal screening

Indexed keywords

HYDROXYPROGESTERONE; STEROID 21 MONOOXYGENASE;

ARTICLE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; HUMAN; MALE; MOLECULAR GENETICS; NEWBORN; SCREENING TEST; SEXUAL DEVELOPMENT;

EID: 0033709845     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050684     Document Type: Article

References (20)

1. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels
2. Screening for congenital adrenal hyperplasia: The Delfia screening test overestimates serum 17-hydroxyprogesterone in preterm infants
3. Congenital adrenal hyperplasia (21-OH) in France. Population genetics
4. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas
5. Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980-1996
6. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency
7. Direct solid-phase time-resolved immunofluorometric assay of cortisol in serum
8. Congenital adrenal hyperplasia and early newborn screening: 17 alpha-hydroxyprogesterone (17-alpha-OHP) during the first days of life
9. How a patient homozygous for a 30 KB deletion of the C4-CYP21 genomic region could have a nonclassical form of 21-hydroxylase deficiency
10. Richtlinien zur Organisation und Durchfuhrung des Neugeborenenscreenings auf angeborene Stoffwechselstorungen und Endokrinopathien in Deutschland
11. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
12. A pilot newborn screening program for congenital adrenal hyperplasia in Alaska
13. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
14. Neugeborenenscreening bei Adrenogenitalem Syndrom (AGS)
15. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
16. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia
17. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden
18. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism
19. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17a-hydroxyprogesterone to gestational age
20. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays